Literature DB >> 19845134

The prevalence of co-morbid depression among employees with type 2 diabetes in a Japanese corporation: a descriptive study using an integrated health database.

Hideaki Arima1, Makiko Miwa, Kazuo Kawahara.   

Abstract

OBJECTIVE: To determine the prevalence of comorbid depression among people with type 2 diabetes using the integrated health database.
METHODS: A total of 6543 people aged 18-65 years were selected from the employees of a Japanese corporation. Using the corporation's integrated health database, which consisted of medical claims data and a self-reported questionnaire from the fiscal year 2000, this study was undertaken to identify the prevalence, the odds ratio and some related factors.
RESULTS: The prevalence of co-morbid depression among people with type 2 diabetes was 2.6%. The crude odds ratio of co-morbid depression among those with type 2 diabetes was 2.20 (95% CI 0.88-5.50). After adjustment for covariates (gender, age, alcohol drinking, smoking, exercise, and dietary restriction), the odds ratio of co-morbid depression among those with type 2 diabetes was 2.33 (0.86-6.33).
CONCLUSIONS: Using the integrated health database, it was suggested that patients with type 2 diabetes were more likely to suffer from depression and there was a relationship between depression and dietary restriction of portion control.

Entities:  

Mesh:

Year:  2007        PMID: 19845134

Source DB:  PubMed          Journal:  J Med Dent Sci        ISSN: 1342-8810


  2 in total

1.  Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study.

Authors:  Hala Ahmadieh; Hadi Itani; Sanaa Itani; Khaled Sidani; Mona Kassem; Kassem Farhat; Mohammad Jbeily; Abdallah Itani
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-08       Impact factor: 3.168

2.  The Association among Glycemic Control and Depression Symptoms in Patients with Type 2 Diabetes.

Authors:  Elvira Hasanovic; Natasa Trifunovic; Irma Dzambo; Hasiba Erkocevic; Adem Cemerlic; Zaim Jatic; Alma Dzubur Kulenovic
Journal:  Mater Sociomed       Date:  2020-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.